Diurno, F <br/><br/>
Eculizumab treatment in patients with COVID-19: preliminary results from real life ASL Napoli 2 Nord experience.  [electronic resource] 

 -  European review for medical and pharmacological sciences  04 2020 
 - 4040-4047 p.  digital 
<br/><br/> Publication Type: Journal Article; Comment 
<br/><br/><label>ISSN: </label>2284-0729 
<br/><br/><label>Standard No.: </label>10.26355/eurrev_202004_20875  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies, Monoclonal, Humanized<br/>Betacoronavirus<br/>COVID-19<br/>Complement Activation<br/>Coronavirus<br/>Coronavirus Infections<br/>Humans<br/>Pandemics<br/>Pneumonia, Viral<br/>SARS-CoV-2<br/>Severe Acute Respiratory Syndrome